ArticleBMC medicine2024

Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database.

Jianxing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.